Summary
In this two-part presentation, Goodwin Procter partner Theresa Kavanaugh examines key provisions of the recently enacted Patent Reform Act, with a particular focus on how it may affect life science companies.
In part one, Kavanaugh discusses the new first-to-file system and new Prioritized Examination Procedure. In part two, she covers new opportunities to challenge third party patents under the new patent act. View the presentation here:
Speakers
- /en/people/k/kavanaugh-theresa
Theresa C. Kavanaugh
Partner